Amid the ongoing opioid crisis, a U.S. lawmaker is pressing a professional medical society that also functions as a patient advocacy group to disclose detailed information about its ties to drug makers over concerns it tried to sway government moves to curb opioid prescribing.

In a March 12 letter, Sen. Ron Wyden (D-Ore.) instructed the American Academy of Pain Medicine to provide a raft of documents, including tax filings; a list of payments from drug and device makers made to the group and its top officer; information about work performed for opioid maker Purdue Pharma; continuing medical education coursework; and its conflict of interest policy, among other things.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy